Fusilev (Spectrum Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Fusilev drug offered from Spectrum Pharmaceuticals, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Spectrum Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: levoleucovorin
SUBSTANCE NAME: LEVOLEUCOVORIN CALCIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-08-15
END MARKETING DATE: 0000-00-00


Fusilev HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFusilev from Spectrum Pharmaceuticals, Inc.
LABELER NAME: Spectrum Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/5mL)
START MARKETING DATE: 2008-08-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68152-101_47e3f48c-6c9e-4116-94a7-a08d4ffa4f6f
PRODUCT NDC: 68152-101
APPLICATION NUMBER: NDA020140

Other LEVOLEUCOVORIN CALCIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.levoleucovorin
Amneal BiosciencesLevoleucovorin
Mylan Institutional LLCLEVOLEUCOVORIN CALCIUM
Spectrum Pharmaceuticals, Inc.Fusilev
West-Ward Pharmaceuticals CorpLevoleucovorin